New Rules at PhRMA to Change Industry's Image

May 11, 2017

The drug industry's main lobbying group is kicking out members that don't spend enough on developing new products.

According to new rules from the Pharmaceutical Research and Manufacturers of America that went into effect this week, in order to remain members, drug firms will have to spend at least 10 percent of their sales on global research and development over three years. They will also need to spend at least $200 million per year on R&D.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

On to Supercomputing

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

More Than a Century Away

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

From the "Cell's View"

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

PLOS Studies Explore Host Responses to Viral Infection, Febrile Illness Culprits

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.

Menu